Health
SK Bioscience starts developing vaccine against Covid-19 variants – Korea Biomedical Review
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness…
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness Innovations (CEPI), an international private organization.
The Korean company will receive up to $14.2 million (about 16 billion won) in research and development funds from CEPI to develop Covid-19 mutants using the development platform of GBP510, for which clinical trials are now underway.
SK Bioscience said it had also received additional…
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoSunshine Coast police disappointed by drink drivers in school zone